Skip to main content

Animations

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Drug Reverses 'Off' Periods in Phase III Trial

    Drug Reverses 'Off' Periods in Phase III Trial

    Sunovion Pharmaceuticals Inc. recently announced positive results of under-the-tongue apomorphine.
    Learn more Save for later

  • $24-Million Public-Private Partnership Expands Investigation of Parkinson's Disease

    $24-Million Public-Private Partnership Expands Investigation of Parkinson's Disease

    The Michael J. Fox Foundation, National Institutes of Health and five industry partners unite to find molecular difference in Parkinson's.
    Learn more Save for later

  • Seizure Medication May Help Movement Symptoms in Lewy Body Dementia

    Seizure Medication May Help Movement Symptoms in Lewy Body Dementia

    The trial is a first step to evaluate the safety and effectiveness of zonisamide for LBD.
    Learn more Save for later

  • Parkinson's Nilotinib Trial Enrolling Participants

    Parkinson's Nilotinib Trial Enrolling Participants

    A Phase II clinical trial to evaluate the safety and tolerability of nilotinib in PD is under way at sites across the US.
    Learn more Save for later

  • Genetic Mutation Links Parkinson's and Crohn's Disease

    Genetic Mutation Links Parkinson's and Crohn's Disease

    This connection, published by researchers from Mount Sinai in New York City, may help better understand and treat these diseases.
    Learn more Save for later

  • Results Are in: Scientific Experts Advance Ways to Detect and Predict PD

    Results Are in: Scientific Experts Advance Ways to Detect and Predict PD

    Research project designed to look for PD biomarkers announces winners.
    Learn more Save for later

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.